These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35492181)

  • 1. Effective estimation of the inhibitor affinity of HIV-1 protease
    Ngo ST; Hong ND; Quynh Anh LH; Hiep DM; Tung NT
    RSC Adv; 2020 Feb; 10(13):7732-7739. PubMed ID: 35492181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of I50V mutant and I50L/A71V double mutant HIV-protease with inhibitor TMC114 (darunavir): molecular dynamics simulation and binding free energy studies.
    Meher BR; Wang Y
    J Phys Chem B; 2012 Feb; 116(6):1884-900. PubMed ID: 22239286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining methods for calculations of binding free energies: LRA, LIE, PDLD-LRA, and PDLD/S-LRA calculations of ligands binding to an HIV protease.
    Sham YY; Chu ZT; Tao H; Warshel A
    Proteins; 2000 Jun; 39(4):393-407. PubMed ID: 10813821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of polar solvation and configurational entropy for design of antiretroviral drugs targeting HIV-1 protease.
    Kar P; Lipowsky R; Knecht V
    J Phys Chem B; 2013 May; 117(19):5793-805. PubMed ID: 23614718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adequate prediction for inhibitor affinity of Aβ
    Ngo ST; Mai BK; Derreumaux P; Vu VV
    RSC Adv; 2019 Apr; 9(22):12455-12461. PubMed ID: 35515829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benchmark of Popular Free Energy Approaches Revealing the Inhibitors Binding to SARS-CoV-2 Mpro.
    Ngo ST; Tam NM; Pham MQ; Nguyen TH
    J Chem Inf Model; 2021 May; 61(5):2302-2312. PubMed ID: 33829781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the energetic basis of binding of currently used drugs against HIV-1 subtype CRF01_AE protease via molecular dynamics simulations.
    Sk MF; Jonniya NA; Kar P
    J Biomol Struct Dyn; 2021 Oct; 39(16):5892-5909. PubMed ID: 32696717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calculate protein-ligand binding affinities with the extended linear interaction energy method: application on the Cathepsin S set in the D3R Grand Challenge 3.
    He X; Man VH; Ji B; Xie XQ; Wang J
    J Comput Aided Mol Des; 2019 Jan; 33(1):105-117. PubMed ID: 30218199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-ligand binding free energy estimation using molecular mechanics and continuum electrostatics. Application to HIV-1 protease inhibitors.
    Zoete V; Michielin O; Karplus M
    J Comput Aided Mol Des; 2003 Dec; 17(12):861-80. PubMed ID: 15124934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An accurate free energy estimator: based on MM/PBSA combined with interaction entropy for protein-ligand binding affinity.
    Huang K; Luo S; Cong Y; Zhong S; Zhang JZH; Duan L
    Nanoscale; 2020 May; 12(19):10737-10750. PubMed ID: 32388542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free energy calculations to estimate ligand-binding affinities in structure-based drug design.
    Reddy MR; Reddy CR; Rathore RS; Erion MD; Aparoy P; Reddy RN; Reddanna P
    Curr Pharm Des; 2014; 20(20):3323-37. PubMed ID: 23947646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual inhibitors for aspartic proteases HIV-1 PR and renin: advancements in AIDS-hypertension-diabetes linkage via molecular dynamics, inhibition assays, and binding free energy calculations.
    Tzoupis H; Leonis G; Megariotis G; Supuran CT; Mavromoustakos T; Papadopoulos MG
    J Med Chem; 2012 Jun; 55(12):5784-96. PubMed ID: 22621689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Molecular Dynamics Simulations and Energy Analysis Unravel the Dynamic Properties and Binding Mechanism of Mutants HIV-1 Protease with DRV and CA-p2.
    Wang R; Zheng Q
    Microbiol Spectr; 2022 Apr; 10(2):e0074821. PubMed ID: 35319278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Studies of a Mechanism for Binding and Drug Resistance in the Wild Type and Four Mutations of HIV-1 Protease with a GRL-0519 Inhibitor.
    Hu G; Ma A; Dou X; Zhao L; Wang J
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient evaluation of binding free energy using continuum electrostatics solvation.
    Huang D; Caflisch A
    J Med Chem; 2004 Nov; 47(23):5791-7. PubMed ID: 15509178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and binding insights into HIV-1 protease and P2-ligand interactions through molecular dynamics simulations, binding free energy and principal component analysis.
    Karnati KR; Wang Y
    J Mol Graph Model; 2019 Nov; 92():112-122. PubMed ID: 31351319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparative Linear Interaction Energy and MM/PBSA Study on SIRT1-Ligand Binding Free Energy Calculation.
    Rifai EA; van Dijk M; Vermeulen NPE; Yanuar A; Geerke DP
    J Chem Inf Model; 2019 Sep; 59(9):4018-4033. PubMed ID: 31461271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational studies of darunavir into HIV-1 protease and DMPC bilayer: necessary conditions for effective binding and the role of the flaps.
    Leonis G; Czyżnikowska Ż; Megariotis G; Reis H; Papadopoulos MG
    J Chem Inf Model; 2012 Jun; 52(6):1542-58. PubMed ID: 22587384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced molecular mechanisms of modified DRV compounds in targeting HIV-1 protease mutations and interrupting monomer dimerization.
    Tang B; Luo S; Wang Q; Gao P; Duan L
    Phys Chem Chem Phys; 2024 Feb; 26(6):4989-5001. PubMed ID: 38258432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origin of decrease in potency of darunavir and two related antiviral inhibitors against HIV-2 compared to HIV-1 protease.
    Kar P; Knecht V
    J Phys Chem B; 2012 Mar; 116(8):2605-14. PubMed ID: 22280246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.